PGY2 residency programs build upon Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency training to develop pharmacist practitioners with knowledge, skills, and abilities as defined in the educational competency areas, goals, and objectives for advanced practice areas. Residents who successfully complete PGY2 residency programs are prepared for advanced patient care or other specialized positions, and board certification in the advanced practice area, if available.
Program Description
The Postgraduate Year Two Pediatric Pharmacy Residency at Seattle Children’s is a 52-week ASHP training program (candidate status) that provides training in the field of pediatrics. Experience is gained in a variety of experiences to meet resident needs and interest areas, with the end goal of becoming a well-rounded pediatric clinical pharmacist with eligibility to sit for the Board-Certified Pediatric Pharmacy Specialist (BCPPS) examination.
Practice Areas
Orientation : 8 weeks (Orientation may be shortened and converted into an elective experience for residents who have completed PGY1 training at Seattle Children’s)
Anticoagulation Training (1 week)
TPN Training (2 weeks)
Central Pharmacy Training (4 weeks)
Competencies (1 week)
Rotations:
Pediatric Medicine: 4 weeks
Pediatric Intensive Care Unit (PICU): 4 weeks
Neonatal Intensive care Unit (NICU): 4 weeks
Hematology Oncology: 4 weeks
Ambulatory Care: longitudinal (~6 months, half day per week)
Anticoagulation Longitudinal Clinic
Cardiac Solid Organ Transplant and Heart Failure Longitudinal Clinic
Drug Information: longitudinal (~4 hours per month)
Formulary monograph
Medication Use Evaluation (MUE)/drug class review
Continuing education seminar (1.0 CPE)
Drug Distribution and Staffing: longitudinal
Every third weekend (2 x8 hour shifts)
One x 3 hour PM shift per week with an additional 3 hour PM shift every 4th week
Project Time: 4 weeks divided throughout the year
Teaching and Precepting: 4 weeks (will precept either a PGY1 resident or APPE student)
Electives (4 rotations)-4 weeks each (16 weeks total)
Bone Marrow Transplant (prerequisite-oncology)
Antimicrobial Stewardship
Emergency Medicine
Infectious Disease
Pediatric and Adolescent Psychiatry
Abdominal Solid Organ Transplant
Cardiac Solid Organ Transplant and Heart Failure (if not completed prior to longitudinal clinic)
Cardiac ICU
Other rotations may be available based on the resident’s interest as approved by the RPD
Special Requirements for Acceptance:Qualifications of the Applicant Going through the Match
Selected applicants will be required to meet Seattle Children’s preceptors for a virtual or in person interview in January or February. The applicant must meet the following general requirements:
**Submission of all materials must be through Phorcas 1) Applicants must be graduates of an Accreditation Council for Pharmacy Education (ACPE) accredited degree program (or one in process of pursuing accreditation) or have a Foreign Pharmacy Graduate Equivalency Committee (FPGEC) certificate from the National Association of Boards of Pharmacy (NABP). 2) Successful completion of an ASHP accredited PGY1 Residency 3) Pre-Interview during PPS at ASHP midyear (or if unable to complete on site may be supplemented with a virtual pre-interview) 4) Licensed or eligible for licensure in the State of Washington: Pharmacy Professions | Washington State Department of Health 5) Participate in the ASHP Pharmacy Resident Matching Program (http://www.natmatch.com/ashprmp). Program code number: 95914 6) Completion of supplemental application material (essay question) 7) Official transcripts 8) Three letters of recommendation (one must be from residency program director or coordinator) 9) Letter of intent 10) CV
Seattle Children’s has 371 licensed beds with 48 Cancer Care Unit beds, over 15,500 annual inpatient admissions, and more than 330,000 ambulatory visits in 2015. Our comprehensive, multidisciplinary team of pediatric cancer experts treats more than 250 newly diagnosed patients with cancer every year and provides follow-up care to more than 12,700 children and adolescents.